指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

ESICM/ESCMID工作组:危重症患者侵袭性念珠菌感染的实用管理

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
PubMed 文献 · Intensive Care Med · 2019-03-25
一句话结论ESICM/ESCMID工作组针对非免疫抑制危重症患者侵袭性念珠菌感染,基于GRADE方法学与改良德尔菲法制定了一套实用推荐,以优化微生物诊断和治疗。

该工作组由临床微生物学、感染病学和重症医学专家组成,针对非免疫抑制危重症患者的侵袭性念珠菌感染(含血流感染和深部感染如腹膜炎)制定推荐。方法学上采用GRADE方法评估推荐并赋予证据等级,通过共识会议及必要时的投票(改良德尔菲过程)决定推荐强度,共识定义为获得超过80%同意的声明。主要目标是提供清晰实用的推荐以优化微生物学诊断和治疗。

要点

  • 适用人群为非免疫抑制的危重症患者,涵盖念珠菌血流感染和深部侵袭性感染如腹膜炎。
  • 推荐制定采用GRADE方法评估证据等级,推荐强度经共识决定,必要时采用改良德尔菲投票。
  • 德尔菲过程中获得超过80%同意的声明被视为达成共识。
  • 工作组的核心目标是优化微生物学诊断和治疗,为临床医生提供清晰实用的推荐。

适用人群与场景

  • 非免疫抑制的危重症患者,收治于重症监护病房。

研究设计与关键结果

  • 该工作组由临床微生物学、感染病学和重症医学专家组成,基于流行病学和临床证据结合专家意见制定推荐。
  • 采用GRADE方法评估推荐并赋予证据等级,推荐强度经共识决定,必要时通过投票(改良德尔菲过程)确定。
  • 德尔菲过程中获得超过80%同意的声明被视为达成共识。

证据类型、等级与局限

  • 证据类型:专家工作组推荐(基于流行病学和临床证据结合专家意见,因缺乏可用科学证据)。
  • 采用GRADE方法评估证据等级,推荐强度经共识及必要时投票决定。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该推荐旨在为临床医生提供清晰实用的推荐以优化非免疫抑制危重症患者侵袭性念珠菌感染的微生物学诊断和治疗。

指南或共识出处

  • ESICM/ESCMID工作组关于危重症患者侵袭性念珠菌感染实用管理的推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The term invasive candidiasis (IC) refers to both bloodstream and deep-seated invasive infections, such as peritonitis, caused by Candida species. Several guidelines on the management of candidemia and invasive infection due to Candida species have recently been published, but none of them focuses specifically on critically ill patients admitted to intensive care units (ICUs).

MATERIAL AND METHODS: In the absence of available scientific evidence, the resulting recommendations are based solely on epidemiological and clinical evidence in conjunction with expert opinion. The task force used the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach to evaluate the recommendations and assign levels of evidence. The recommendations and their strength were decided by consensus and, if necessary, by vote (modified Delphi process). Descriptive statistics were used to analyze the results of the Delphi process. Statements obtaining > 80% agreement were considered to have achieved consensus.

CONCLUSIONS: The heterogeneity of this patient population necessitated the creation of a mixed working group comprising experts in clinical microbiology, infectious diseases and intensive care medicine, all chosen on the basis of their expertise in the management of IC and/or research methodology. The working group's main goal was to provide clinicians with clear and practical recommendations to optimize microbiological diagnosis and treatment of IC. The Systemic Inflammation and Sepsis and Infection sections of the European Society of Intensive Care Medicine (ESICM) and the Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) therefore decided to develop a set of recommendations for application in non-immunocompromised critically ill patients.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019. PMID: 30911804. doi:10.1007/s00134-019-05599-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。